Navigation Links
'Smart' genetic therapy helps the body to heal itself

of the gene that code for the disease), the processing of the genetic code for dystrophin ?a protein important for the muscle fibre membrane - can be manipulated in such a manner that certain units ('exons') are skipped. In this way, the readability of the code can be restored and the progress of DMD delayed or even stopped.

In collaboration with the Dutch biotech company Prosensa BV, and supported by the national and international Duchenne Parent Projects, and governmental and charity funds, Dr. J. van Deutekom and her team will soon start a clinical trial, based on intramuscular injection of a single dose of an anti-sense drug that induces the skipping of exon 51 from the DMD gene. Six Dutch DMD patients aged between 8 and 16 years with genetic mutations that are correctable by skipping that particular exon will take part.

This human trial is being supported by animal work. The team has used the muscular dystrophy mouse model to study optimal dose regimes, and further study exon skipping levels. This study found no clinical adverse signs, and the restoration of dystrophin levels, even in the heart.

"Of all the different strategies against DMD currently being contemplated," said Professor van Ommen, "this is the one closest to clinical application. The patients in the trial have already been pre-screened, and we have seen the effect of the anti-sense drug in their isolated and cultured muscle cells. We are optimistic that this small scale trial will be the precursor of major clinical studies, which will lead in turn to a safe and efficient full body treatment for DMD patients. Currently no therapy is available for this disease, which represents a huge psychosocial and economic burden to patients, carers and society."


'"/>

Source:European Society of Human Genetics


Page: 1 2 3 4

Related biology news :

1. Smart nanoprobes light up disease
2. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Mouse brain tumors mimic those in human genetic disorder
5. Scientists identify genetic pathways essential to RNA interference
6. Researchers trace evolution to relatively simple genetic changes
7. Key mechanism in genetic inheritance during cell division identified
8. Scientists identify genetic pathways essential to RNA interference
9. MUHC scientists describe genetic resistance to rampant virus
10. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
11. Montreal researchers probe the genetic basis of memory
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Smart genetic therapy helps the body heal itself

(Date:6/17/2015)... Germany , June 17, 2015 ... Standard: QIA) today launched new Investigator ® STR assay ... the United States . The new genetic ... key genomic markers (short tandem repeats or STRs) for DNA ... evaluate the quality of DNA in each sample, a novel ...
(Date:6/16/2015)... June 16, 2015 /CNW Telbec/ - handyem Inc. ... around the incorporation of handyem,s HPC-150 portable flow ... the Mo-POD™. This unprecedented model of mobile laboratory ... at the Pennsylvania Convention ... 15 th to 18 th 2015. ...
(Date:6/16/2015)... -- Fingerprint Cards (FPC) raises the revenue guidance ... to at least 340 MSEK to that it will amount ... market growth and orders received the revenue guidance for 2015 ... 2015 will exceed 1,500 MSEK to an updated guidance that ... Due to receipt of orders of touch fingerprint sensors ...
Breaking Biology News(10 mins):QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
... Mich. Where there,s water there,s life even in ... and subzero temperatures. While Lake Vida, located in the ... never be a vacation destination, it is home to some ... Proceedings of the National Academy of Sciences , Nathaniel ...
... The Algae Biomass Organization, the trade association for the U.S. ... California at San Diego study that concludes, for the first ... as freshwater algae in producing biofuels. The research is documented ... of the scientific journal Algal Research . "What ...
... developed in atomic physics over the past few years are ... ions at temperatures just above absolute zero. Scientists from Bangalore ... ions can also be cooled through contact with cold atoms ... a stable condition for longer periods of time. This finding ...
Cached Biology News:Hearty organisms discovered in bitter-cold Antarctic brine 2Algae Biomass Organization hails new UCSD study showing saltwater algae viable for biofuels 2Scientists from Bangalore and Mainz develop new methods for cooling of ions 2
(Date:7/2/2015)... 2, 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an ... monetization of intellectual property, today announced a litigation update. ... v. Verizon Services Corp. et al. , Case No. ... Eastern District of Virginia , the ... interpreting certain key claims in favor of the Defendants ...
(Date:7/1/2015)... PARK, N.C. and PARIS ... research firm AgBiome, and Genective, key developer of ... accelerate the discovery of new generations of insect ... for insect control to counter the realities of ... with Genective, aligning AgBiome,s unique insect control technology ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... combat pathogen transmission. CTI’ new Medical Joysticks have an impermeable molecular barrier ... have an operator control device that will increase healthcare worker safety and reduce ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... Bio-Optronics, Inc., a leader in healthcare workflow software, announces ... that can simultaneously handle the most intricate scheduling policies, demand, ... , , Physician and healthcare ... , Bio-Optronics President & CEO, Dan Kerpelman, ...
... Environmental Tectonics Corporation,s (OTC Bulletin Board: ETCC) ("ETC" or ... Support Technologies (LST), a wound care management group located in ... XD monoplace hyperbaric chambers in Hudson Valley Hospital, Cortlandt Manor, ... To date LST has purchased from ETC and operates over ...
... 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a ... to exclusively license seven cancer antigens from Immunotope ... specifically target breast, ovarian and prostate cancers. IVT ... delivery platform to develop DPX-0907, a therapeutic cancer ...
Cached Biology Technology:NEW Momentum(TM) Physician and Staff Scheduling Software for Imaging Centers, OB/GYN, and Other Specialty Practices Improves Productivity and Equity in Scheduling 2Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers 2Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers 3Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers 4ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens 2